Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公布了 FXR314 的第 2 阶段结果；表示 “接受 FXR314 的研究受试者肝脏脂肪含量比基准线减少了统计学上的显著性”
Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公布了 FXR314 的第 2 阶段结果；表示 “接受 FXR314 的研究受试者肝脏脂肪含量比基准线减少了统计学上的显著性”
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。